Sifting through countless of stocks in the Health Care Providers & Services industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Alignment Healthcare, Inc., Astrana Health or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Alignment Healthcare, Inc., Astrana Health and Inc. compare based on key financial metrics to determine which better meets your investment needs.

About Alignment Healthcare, Inc., Astrana Health and Inc.

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.

Latest Health Care Providers & Services and Alignment Healthcare, Inc., Astrana Health, Inc. Stock News

As of July 31, 2026, Alignment Healthcare, Inc. had a $3.1 billion market capitalization, compared to the Health Care Providers & Services median of $1.7 million. Alignment Healthcare, Inc.’s stock is down 24.8% in 2026, down 23.6% in the previous five trading days and up 14.23% in the past year.

Currently, Alignment Healthcare, Inc.’s price-earnings ratio is 75.0. Alignment Healthcare, Inc.’s trailing 12-month revenue is $4.6 billion with a 0.9% net profit margin. Year-over-year quarterly sales growth most recently was 31.5%. Analysts expect adjusted earnings to reach $0.493 per share for the current fiscal year. Alignment Healthcare, Inc. does not currently pay a dividend.

As of July 31, 2026, Astrana Health, Inc. had a $1.6 billion market cap, putting it in the 51st percentile of all stocks. Astrana Health, Inc.’s stock is up 43.3% in 2026, down 11.8% in the previous five trading days and up 47.67% in the past year.

Currently, Astrana Health, Inc.’s price-earnings ratio is 58.4. Astrana Health, Inc.’s trailing 12-month revenue is $3.5 billion with a 0.9% net profit margin. Year-over-year quarterly sales growth most recently was 55.6%. Analysts expect adjusted earnings to reach $2.920 per share for the current fiscal year. Astrana Health, Inc. does not currently pay a dividend.

How We Compare Alignment Healthcare, Inc., Astrana Health and Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Alignment Healthcare, Inc., Astrana Health and Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Alignment Healthcare, Inc., Astrana Health and Inc. Stock Value Grades

Company	Ticker	Value
Alignment Healthcare, Inc.	ALHC	F
Astrana Health, Inc.	ASTH	C

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.

Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.

Alignment Healthcare, Inc. has a Value Score of 20, which is Ultra Expensive. Astrana Health, Inc. has a Value Score of 52, which is Average.

The Value Stock Winner: No Clear Winner

Neither Alignment Healthcare, Inc., Astrana Health or Inc. has a high enough value grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolio. It’s important to look at a wide range of financial metrics in order to determine if Alignment Healthcare, Inc., Astrana Health or Inc. is the better investment when it comes to value.

Alignment Healthcare, Inc., Astrana Health and Inc.’s Quality Grades

Company	Ticker	Quality
Alignment Healthcare, Inc.	ALHC	B
Astrana Health, Inc.	ASTH	C

Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.

The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.

The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.

Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.

Alignment Healthcare, Inc. has a Quality Score of 62, which is Strong. Astrana Health, Inc. has a Quality Score of 46, which is Average.

The Quality Grade Winner: Alignment Healthcare, Inc.

As you can clearly see from the Quality Grade breakdown above, Alignment Healthcare, Inc. has a better overall quality grade than Astrana Health, Inc.. For investors who are looking for companies with higher quality than others in the same industry, Alignment Healthcare, Inc. could be a good stock to add to their portfolios. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Alignment Healthcare, Inc., Astrana Health and Inc.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Alignment Healthcare, Inc.	ALHC	B
Astrana Health, Inc.	ASTH	C

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Alignment Healthcare, Inc. has a Earnings Estimate Score of 78, which is Positive. Astrana Health, Inc. has a Earnings Estimate Score of 55, which is Neutral.

The Earnings Estimate Revisions Grade Winner: Alignment Healthcare, Inc.

As you can clearly see from the Earnings Estimate Revisions Grade breakdown above, Alignment Healthcare, Inc. has a better Earnings Estimate Revisions Grade than Astrana Health, Inc.. For those who are specifically looking for companies with better short-term prospects when compared to other companies in the same industry, Alignment Healthcare, Inc. could be a good stock to invest in. However, it’s important to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Other Alignment Healthcare, Inc., Astrana Health and Inc. Grades

In addition to Quality, Value and Estimate Revisions, A+ Investor also provides grades for Growth and Momentum.

Momentum grades help uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming.

Growth investing builds on the idea that stocks of companies exhibiting strong, consistent and prolonged growth outperform those of slower-growth companies. AAII measures growth through consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Alignment Healthcare, Inc., Astrana Health and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Alignment Healthcare, Inc., Astrana Health or Inc. Stock?

Overall, Alignment Healthcare, Inc. stock has a Value Score of 20, Estimate Revisions Score of 78 and Quality Score of 62.

Astrana Health, Inc. stock has a Value Score of 52, Estimate Revisions Score of 55 and Quality Score of 46.

Comparing Alignment Healthcare, Inc., Astrana Health and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.